Hair loss (alopecia) has been reported since Mounjaro came on the market, but it was not a common side effect in clinical trials
If the target is the brain, gut-brain axis, or immune system, the focus is internal (KLOW)
It belongs to a class of drugs known as GLP-1 receptor agonists, which work by mimicking the hormone GLP-1 (glucagon-like peptide-1) to regulate blood sugar levels and appetite
Each individual dose is smaller, potentially reducing per-dose side effects
We discuss overcoming barriers, patient counseling, obesity pathophysiology, motivational interviewing, tools and tips from a weight loss program, and how to discuss medications for weight loss including phentermine/topiramate, bupropion/naltrexone, orlistat, oral superabsorbent hydrogel, and GLP1 agonists